What’s Behind the Surge in Pharmaceutical Deals?

Aug. 25 (Bloomberg) –- Bloomberg’s Shannon Pettypiece discusses Roche’s $8.3 billion offer for InterMune and big pharmaceutical deals. She speaks on “Bottom Line.” (Source: Bloomberg)

Gold Bulls, Oil Bears: Keeping Up With Commodities
44:48 - James Steel, chief commodities analyst at HSBC Securities, and Bloomberg Intelligence's Peter Pulikkan examine the bull case for gold and the IEA's call boosting estimates for surplus oil. They speak on "Bloomberg Markets." (Source: Bloomberg)
  • Changing the Narrative on ‘Brexit’
  • Ray Dalio's Honest 'Radical Transparency' Approach
  • Deutsche Bank's Checklist to Regain Investor Trust